메뉴 건너뛰기




Volumn 9, Issue 6, 2016, Pages

Factors Associated with Noncompletion during the Run-In Period before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial

Author keywords

angiotensin system; angiotensin converting enzyme inhibitor; clinical trial; heart failure; LCZ696; neprilysin; renin; sacubitril

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SACUBITRIL PLUS VALSARTAN; AMINOBUTYRIC ACID DERIVATIVE; TETRAZOLE DERIVATIVE;

EID: 84975795326     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002735     Document Type: Article
Times cited : (63)

References (10)
  • 1
    • 53449094159 scopus 로고    scopus 로고
    • Beyond the randomized clinical trial: The role of effectiveness studies in evaluating cardiovascular therapies
    • Nallamothu BK, Hayward RA, Bates ER, Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008 118 1294 1303. doi: 10.1161/CIRCULATIONAHA.107.703579
    • (2008) Circulation , vol.118 , pp. 1294-1303
    • Nallamothu, B.K.1    Hayward, R.A.2    Bates, E.R.3
  • 3
    • 84880206504 scopus 로고    scopus 로고
    • Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: Rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
    • McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Committees and Investigators Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail 2013 15 1062 1073. doi: 10.1093/eurjhf/hft052
    • (2013) Eur J Heart Fail , vol.15 , pp. 1062-1073
    • McMurray, J.J.1    Packer, M.2    Desai, A.S.3    Gong, J.4    Lefkowitz, M.P.5    Rizkala, A.R.6    Rouleau, J.7    Shi, V.C.8    Solomon, S.D.9    Swedberg, K.10    Zile, M.R.11
  • 4
    • 0038313209 scopus 로고    scopus 로고
    • Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
    • Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW, Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003 41 2029 2035. doi: 10.1016/S0735-1097(03)00417-0
    • (2003) J Am Coll Cardiol , vol.41 , pp. 2029-2035
    • Kittleson, M.1    Hurwitz, S.2    Shah, M.R.3    Nohria, A.4    Lewis, E.5    Givertz, M.6    Fang, J.7    Jarcho, J.8    Mudge, G.9    Stevenson, L.W.10
  • 5
    • 2642616191 scopus 로고    scopus 로고
    • Run-in periods in randomized trials: Implications for the application of results in clinical practice
    • Pablos-Méndez A, Barr RG, Shea S, Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998 279 222 225. doi: 10.1001/jama.279.3.222
    • (1998) JAMA , vol.279 , pp. 222-225
    • Pablos-Méndez, A.1    Barr, R.G.2    Shea, S.3
  • 8
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 325 293 302. doi: 10.1056/NEJM199108013250501
    • (1991) N Engl J Med , vol.325 , pp. 293-302
  • 9
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999 353 2001 2007. doi: 10.1016/S0140-6736(99)04440-2
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 10
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996 334 1349 1355. doi: 10.1056/NEJM199605233342101
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3    Colucci, W.S.4    Fowler, M.B.5    Gilbert, E.M.6    Shusterman, N.H.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.